← Browse by Condition
Medical Condition

endometrial carcinoma ec

Total Trials
2
Recruiting Now
2
Trial Phases
Phase 1, Phase 2

ClinicalMetric tracks all active clinical trials for endometrial carcinoma ec sourced from ClinicalTrials.gov. Each listing includes the NCT identifier, current recruitment status, phase, primary endpoints, sponsor, estimated enrollment, and participating countries — updated daily as new studies open and status changes.

  • Recruiting trials currently enrolling participants, with eligibility criteria and age requirements
  • Phase 1–4 studies from early safety trials to post-marketing surveillance
  • NIH, pharmaceutical sponsor, and academic medical center studies worldwide
  • AI-powered plain-language summary available for every trial listing
Trial Phases
Phase 1
1
Phase 2
1
Top Sponsors
GV20 Therapeutics 1 trial
National Cancer Institute, Naples 1 trial
NCT07070518 Phase 1, Phase 2
Recruiting

Study of GV20-0251 in Participants With Solid Tumor Malignancies

Enrollment
350 pts
Location
China
Sponsor
GV20 Therapeutics
View Trial →
NCT06893861
Recruiting

Assessment of the Effectiveness of the Metabolomic Approach in Screening for Endometrial Cancer

Enrollment
3,100 pts
Location
Italy
Sponsor
National Cancer Institute, Nap...
View Trial →